Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

LABORATORY AND ANALYTICAL – MASS SPECTROMETRY

Agilent Technologies Europe : 29 May, 2009  (Special Report)
FOCUS ZONE REPORT Agilent Technologies and Anderson Forschung Group (AFG) are collaborating to develop quantitative peptide assays to speed protein biomarker discovery and validation.
The collaboration will combine AFG's stable isotope standards and capture by anti-peptide antibodies (SISCAPA) technology with Agilent's 1200 Series HPLC-Chip and 6400 Series triple quadrupole mass spectrometers (MS). The combination will be used to develop methods for measuring the amounts of large numbers of peptides in digests of complex samples such as plasma. The results will benefit both organizations, and financial details were not disclosed.

'We're proud to be partnering with a thought leader like Dr. Anderson to develop improvements in clinical mass spectrometry,' said Gustavo Salem, Agilent’s Vice President and General Manager, Biological Systems Division. 'One of the greatest challenges to delivering useful knowledge using the protein Biomarker discovery paradigm is achieving effective, reproducible and highly sensitive peptide quantitation.'

'SISCAPA assays for candidate biomarkers can benefit substantially from the reproducibility and sensitivity of Agilent's platform, and we look forward to optimizing this combination,' said Leigh Anderson, AFG's Chief Executive Officer.

The SISCAPA method utilises antibody-coated magnetic beads and a rotary magnetic bead trap device to capture target peptides, which are then measured using a nanoflow LC-MS/MS system. The goal is to accurately measure the quantities of very small amounts of peptides in sample digests, creating a useful research tool with potential uses in advanced diagnostics.

The Agilent 1200 Series HPLC-Chip/MS system is a microfluidic platform that integrates LC columns, connection capillaries, and nanospray emitter in a polymer chip, providing uncompromised chromatographic performance, even with small sample input amounts. The credit card-sized device is inserted into Agilent's HPLC-Chip Cube to interface with the MS. Chip loading, solvent and sample delivery, high pressure switching of flows, and chip positioning in the MS source are all automated.

The Agilent 6400 Series triple quadrupole LC/MS systems provides femtogram-level sensitivity across a broad mass range.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo